GLP 1 Quiz
B. Enhancing insulin secretion and decreasing glucagon release
Rationale: GLP-1 receptor agonists promote weight loss by increasing insulin secretion
and reducing glucagon release. By modulating appetite and promoting satiety, they help
decrease calorie intake and facilitate weight loss. - questions and answers1. What is the
primary mechanism of action of GLP-1 receptor agonists in weight loss?
A. Increasing glucose absorption in the intestines
B. Enhancing insulin secretion and decreasing glucagon release
C. Reducing blood pressure and cholesterol levels
D. Directly removing excess fat from adipose tissue
B. Known hypersensitivity to GLP-1
Rationale: Known hypersensitivity to GLP-1 is a contraindication for using GLP-1 and
GIP receptor agonist medications. These drugs, designed to manage obesity and Type
2 diabetes, mimic incretin hormones to regulate glucose metabolism. However, if a
patient is allergic to the medication's components, its use can result in severe adverse
effects and must be avoided in such cases. - questions and answersWhich of the
following is NOT an indication for GLP-1 and GIP medication use?
A. Obesity with unsuccessful diet and exercise intervention
B. Known hypersensitivity to GLP-1
C. Type 2 diabetes with inadequate glycemic control
D. Overweight individuals with cardiovascular risk factors
A. Patients with a history of pancreatitis
Rationale: GLP-1 and GIP medications are typically not recommended for patients with
a history of pancreatitis, as they may worsen the condition. These medications have
been associated with an increased risk of pancreatitis, which can be dangerous for
individuals with a prior history. Additionally, individuals with a history or family history of
Thyroid Medullary Cancer should avoid using these peptides. Prescribing GLP-1 and
GIP receptor agonists require careful consideration of the patient's medical background
to ensure their safety. Those with a BMI below 25 can be prescribed this medication to
assist in glycemic control if diagnosed with diabetes. - questions and answersWhich
population is contraindicated from using GLP-1 and GIP medications?
B. Enhancing insulin secretion and decreasing glucagon release
Rationale: GLP-1 receptor agonists promote weight loss by increasing insulin secretion
and reducing glucagon release. By modulating appetite and promoting satiety, they help
decrease calorie intake and facilitate weight loss. - questions and answers1. What is the
primary mechanism of action of GLP-1 receptor agonists in weight loss?
A. Increasing glucose absorption in the intestines
B. Enhancing insulin secretion and decreasing glucagon release
C. Reducing blood pressure and cholesterol levels
D. Directly removing excess fat from adipose tissue
B. Known hypersensitivity to GLP-1
Rationale: Known hypersensitivity to GLP-1 is a contraindication for using GLP-1 and
GIP receptor agonist medications. These drugs, designed to manage obesity and Type
2 diabetes, mimic incretin hormones to regulate glucose metabolism. However, if a
patient is allergic to the medication's components, its use can result in severe adverse
effects and must be avoided in such cases. - questions and answersWhich of the
following is NOT an indication for GLP-1 and GIP medication use?
A. Obesity with unsuccessful diet and exercise intervention
B. Known hypersensitivity to GLP-1
C. Type 2 diabetes with inadequate glycemic control
D. Overweight individuals with cardiovascular risk factors
A. Patients with a history of pancreatitis
Rationale: GLP-1 and GIP medications are typically not recommended for patients with
a history of pancreatitis, as they may worsen the condition. These medications have
been associated with an increased risk of pancreatitis, which can be dangerous for
individuals with a prior history. Additionally, individuals with a history or family history of
Thyroid Medullary Cancer should avoid using these peptides. Prescribing GLP-1 and
GIP receptor agonists require careful consideration of the patient's medical background
to ensure their safety. Those with a BMI below 25 can be prescribed this medication to
assist in glycemic control if diagnosed with diabetes. - questions and answersWhich
population is contraindicated from using GLP-1 and GIP medications?
